MREO

Mereo BioPharma
MREO

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$1.5
134% upside
High target

3 analyst ratings

positive
1  neutral
33%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
BTIG
BTIG
Julian Harrison
33% 1-yr MREO win rate
16 Jan ‘26 16 hours ago
Needham
Needham
Gil Blum
50% 1-yr MREO win rate
13 Jan ‘26 3 days ago
Jefferies
Jefferies
Maury Raycroft
30 Dec ‘25 17 days ago
LifeSci Capital
LifeSci Capital
Cory Jubinville
29 Dec ‘25 18 days ago